PGY2 Residency in Hematology/Oncology Pharmacy Practice

Setting

Stanford Hospital & Clinics is world-renowned for advanced patient care, particularly for the treatment of rare, complex disorders in areas such as cardiac care, cancer treatment, neurosciences, surgery, and organ transplants. It is recognized by U.S. News & World Report as one of “America’s Best Hospitals” and currently ranked #15 in the U.S. Stanford Hospital & Clinics has a close relationship with both the Stanford University School of Medicine and Lucile Packard Children’s Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. The hospital is located on the Stanford University campus in Palo Alto, California; it is about 20 miles north of San Jose and about 40 miles south of San Francisco.

Clinical pharmacists at Stanford Hospital & Clinics cover all acute patient care areas, including Hematology, Oncology, Bone Marrow Transplant, Cardiology, Critical Care, General Surgery, Internal Medicine, Psychiatry, and Solid Organ Transplant. In addition, ambulatory care clinical pharmacists are responsible for Oral Anticoagulation, Transplant Diabetes, and Oncology clinics.

Program Overview

The Hematology/Oncology Residency at Stanford Hospital & Clinics is a PGY2 specialty training program that offers extensive hematology and oncology experiences at Sanford Comprehensive Cancer Center currently ranked top 10 in the nation.  One applicant is accepted per year.

The program is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with cancer and on the care of patients with hematologic disorders.  Residency graduates will be equipped to participate as integral members of interdisciplinary teams caring for individuals with cancer, assuming responsibility for pharmaceutical care.  They will be able to manage the range of facilities that prepare and distribute anticancer medications – including the safe preparation, handling, and disposal of those which are hazardous.

The wealth of residency graduates’ knowledge of neoplastic diseases, cancer-related and cancer treatment-related disorders, and the participation on interdisciplinary teams involved with the treatment of individuals with cancer will produce a pharmacist who can successfully serve health care organizations as the ultimate resource for information about anticancer medications and for decision-making affecting the care of these patients. This includes leadership in formulary decision-making for cancer-related medications.  Because of the prominent use of investigational drugs in the treatment of individuals with cancer, the resident will also possess the skills to practice effectively in clinical environments participating in clinical research efforts.

Groomed for practice leadership, oncology pharmacy residency graduates can be expected to continue their pursuit of expertise in practice; to possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for individuals with cancer; to deliver effective training to those health care professionals; and to contribute to public health efforts for health improvement, wellness, and cancer screening and prevention. 


Program Structure

The Hematology/Oncology Specialty Residency is new to Stanford in 2008, and is currently seeking accreditation by the American Society of Health System Pharmacists (ASHP).  The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.  Residency experiences will be as follows:

Required Program Activities:

Elective Rotations:

Program Goals

  1. To serve as an authoritative resource on the optimal use of medications used to treat patients with cancer.
  2. Optimize the outcomes of the care of individuals with cancer by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
  3. Manage and improve the medication-use process in hematology/oncology patient care areas.
  4. Demonstrate excellence in the provision of training or educational activities for health care professionals and health care professionals in training.
  5. Promote health improvement, wellness, and cancer prevention.
  6. Sustain the ongoing development of expertise and professionalism in the practice of hematology/oncology pharmacy.
  7. Conduct hematology/oncology pharmacy practice research.
  8. Function effectively in hematology/oncology settings participating in clinical investigations.

 

Specialized Residency Requirement

  1. Complete and present a research project at the Western States Conference and/or HOPA annual meeting.
  2. Participate in teaching activities with PGY1 residents and pharmacy students
  3. Prepare and present drug monograph for the Pharmacy & Therapeutics committee
  4. Staff 16 hours every 4 weeks
  5. Attend hematology/oncology related committee meetings and teaching sessions

Preceptors

Yi-an (Anne) Chen, Pharm.D., BCOP. graduated from the University of California, San Francisco. She completed a pharmacy practice residency at Stanford Hospital and Clinics. She has been practicing as a clinical pharmacist specializing in hematology and oncology since 2004.

Latanya Dean, Pharm.D. received her degree from the University of Washington in 2001. She completed a general practice residency at Stanford in June 2002. After residency she accepted a clinical position at Stanford and currently works in the Cancer Center as an oncology clinical pharmacist.

Fu-ying Lee-Lam, R.Ph. received her B.S from St. John’s University, New York. She worked at Memorial Sloan Kettering during her internship and stayed for 7 years. She has been at Stanford since 1995 and her area of specialty is Bone Marrow Transplant.

Faye Tsung, Pharm.D. received her degree at Philadelphia College of Pharmacy and Science. In 1995 she completed an oncology residency at University of Illinois at Chicago. She joined Stanford in 2002 and currently works as a BMT/Oncology pharmacist.

Joanna Wang, Pharm.D. graduated from University of Southern California in 1991 and completed a residency at UCLA. She worked for 5 years at UCI medical center in the critical care unit. She began working at Stanford in 1997 and is currently the clinical pharmacist in Bone Marrow Transplant.

Alice Chang, Pharm.D., received her degree from the University of Colorado in 1998. She completed an ambulatory care residency at University of Illinois at Chicago and worked at Olive-View UCLA Medical Center for 4 years before joining Stanford in 2003. She is currently practicing as a clinical oncology pharmacist in the Cancer Center.

Magdalena Cudny, Pharm.D., BCPS, received her degree from the University of California, San Francisco in 2006.  She completed a pharmacy practice residency at Stanford Hospital and Clinics.  She worked as a clinical pharmacist for 2 years before transitioning into the hematology and oncology specialty area at Stanford Hospital.

Samit Patel, Pharm.D., graduated from the University of Houston in 2007. He completed his pharmacy practice residency at Presbyterian Hospital of Dallas/Texas Tech University Health Science Center. Then went on the complete an oncology residency at Stanford Hospital and Clinics and was hired on as a clinical pharmacist. 

Compensation and Benefit

PGY2 residents receive a competitive annual stipend with full benefits, including an excellent healthcare benefits package and 10 days paid time off. In addition, the PGY2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.

Qualifications

Participation in our Specialized Residency in Critical Care Pharmacy Practice requires a Pharm.D. degree from an ACPE-accredited College or School of Pharmacy, completion of an ASHP-accredited PGY1 residency program, and CA licensure/eligibility (must obtain licensure within 3 months of start date of residency) and enrollment in the ASHP Residency Match Program (http://www.natmatch.com/ashprmp/reglink.htm).

 

Application Process

  1. Candidates interested in applying must complete the online SHC application process at www.WorkatStanfordHospital.com, job #15830. Please attach the following items to your online application:

    • Personal statement outlining career goals, areas of interest and reasons for applying to the residency program at Stanford Hospital and Clinics.
    • Curriculum vitae
  2. Three letters of recommendation AND recommendation evaluation forms submitted electronically from the recommender to SaPatel@stanfordmed.org

    • Recommendation evaluation form is located here
    • Please have your recommenders follow up with a signed hard copy and mail the recommendation materials to:

    3. Samit Patel, Pharm.D.,
    Department of Pharmacy,
    Stanford Hospital and Clinics,
    300 Pasteur Drive, Room H0301,
    Stanford, CA 94305-5616

  3. College of Pharmacy transcript submitted directly from your school to: Samit Patel, Pharm.D., Department of Pharmacy, Stanford Hospital and Clinics, 300 Pasteur Drive, Room H0301, Stanford, CA 94305-5616.

Selected applicants will be required to visit Stanford Hospital and Clinics for an on-site interview in January thru February 2010.  For consideration, the online application and all supporting documentation must be received by January 10, 2010.

Selected applicants will be required to visit Stanford Hospital and Clinics for an on-site interview in January thru February 2010.  For consideration, the online application and all supporting documentation must be received by January 10, 2010.

On-Site Interview

After all application materials are reviewed, the candidate will be contacted for a half-day on-site interview. The date of the interview is negotiable based on candidate and interview team schedules. The candidate is required to give a 15 minute Powerpoint presentation on any pharmacy-related topic (oncology topic preferred).

Stanford Medicine Resources:

Footer Links: